| Reporting Segmentarrow_drop_down | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Wound Care |
Biologically-Derived Tissue Scaffolding Products; sold through distributor
These companies manufacture tissue scaffolding products, primarily from placental tissue (such as amniotic membrane allografts) and sell them through wholesalers or distributors. These are used for skin wound healing and dermal reconstruction.
|
54.84M | 84.38% |
| Wound Care |
Implantable Structural Support Devices (outsourced); private insurance
These companies outsource the manufacturing of structural implants for the body. Examples include steel bars, bone grafts, etc. Their products are paid for primarily through private health insurance.
|
9.95M | 15.31% |
| Wound Care |
Licensing of Bleeding Control Products
These companies license patents for the production of bleeding control products. These products stop bleeding using thrombin or similar biochemically active ingredients that initiate the clotting of blood.
|
0.2M | 0.31% |
| keyboard_arrow_down |
Wound Care
Biologically-Derived Tissue Scaffolding Products; sold through distributor
|
54.84M | 84.38% |
| keyboard_arrow_right |
These companies manufacture tissue scaffolding products, primarily from placental tissue (such as amniotic membrane allografts) and sell them through wholesalers or distributors. These are used for skin wound healing and dermal reconstruction.
|
||
| keyboard_arrow_down |
Wound Care
Implantable Structural Support Devices (outsourced); private insurance
|
9.95M | 15.31% |
| keyboard_arrow_right |
These companies outsource the manufacturing of structural implants for the body. Examples include steel bars, bone grafts, etc. Their products are paid for primarily through private health insurance.
|
||
| keyboard_arrow_down |
Wound Care
Licensing of Bleeding Control Products
|
0.2M | 0.31% |
| keyboard_arrow_right |
These companies license patents for the production of bleeding control products. These products stop bleeding using thrombin or similar biochemically active ingredients that initiate the clotting of blood.
|
||